Biosynex SA (Biosynex A) aktie
0DL.F
Biosynex A
Market Cap
$17,878,956
Om Biosynex SA (Biosynex A) aktie
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.
Företagsinformation
67400 Illkirch-Graffenstaden, France
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.